{
    "organizations": [],
    "uuid": "088bdc1a7df362ef8593262bbd22f6f5278c2c16",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ampio-updates-regulatory-clinical/brief-ampio-updates-regulatory-clinical-and-nyse-activities-idUSASC09VRU",
    "ord_in_thread": 0,
    "title": "BRIEF-Ampio Updates Regulatory, Clinical And NYSE Activities",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - Ampio Pharmaceuticals Inc:\n* AMPIO UPDATES REGULATORY, CLINICAL AND NYSE ACTIVITIES * BEGUN PRELIMINARY DISCUSSIONS WITH FDA ON DETAILS OF BLA SUBMISSION PROCESS FOR AMPION\n* RECEIVED NOTIFICATION LETTER FROM NYSE CONFIRMING CO IS NOW IN FULL COMPLIANCE WITH LISTING REQUIREMENTS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-13T05:44:00.000+03:00",
    "crawled": "2018-04-13T17:47:46.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "ampio",
        "pharmaceutical",
        "inc",
        "ampio",
        "update",
        "regulatory",
        "clinical",
        "nyse",
        "activity",
        "begun",
        "preliminary",
        "discussion",
        "fda",
        "detail",
        "bla",
        "submission",
        "process",
        "ampion",
        "received",
        "notification",
        "letter",
        "nyse",
        "confirming",
        "co",
        "full",
        "compliance",
        "listing",
        "requirement",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}